STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] IM Cannabis Corp. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of November 2025  (Report No. 2).
 
Commission File Number: 001-40065

IM Cannabis Corp.
(Exact Name of Registrant as Specified in Charter)

Kibbutz Glil Yam, Central District, Israel 4690500
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒      Form 40-F ☐
 
This Report of Foreign Private Issuer on Form 6-K consists of IM Cannabis Corp.’s (the “Company”): (i) Unaudited Interim Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2025, which are attached hereto as Exhibit 99.2; (ii) Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended September 30, 2025, which is attached hereto as Exhibit 99.3; and (iii) a press release issued by the Company on September 13, 2025 titled “IM Cannabis Reports Third Quarter 2025 Financial Results”, which is attached hereto as Exhibit 99.1.

This Report of Foreign Private Issuer on Form 6-K, excluding the section titled “Management Commentary” of Exhibit 99.1, Exhibit 99.4 and Exhibit 99.5 hereto, is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-288346 and File No. 333-289571) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
 


EXHIBIT INDEX
 
99.1 News Release dated November 13, 2025
99.2 Interim Consolidated Financial Statements for the three and nine months ended September 30, 2025
99.3 Management's Discussion and Analysis for the three and nine months ended September 30, 2025
99.4 Certification of Interim Filings by CFO dated November 13, 2025
99.5 Certification of Interim Filings by CEO dated November 13, 2025



SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
IM CANNABIS CORP.
 
(Registrant)
 
 
 
Date: November 13, 2025
By:
/s/ Oren Shuster
 
Name:
Oren Shuster
 
Title:
Chief Executive Officer and Director


Im Cannabis Corp

NASDAQ:IMCC

IMCC Rankings

IMCC Latest News

IMCC Latest SEC Filings

IMCC Stock Data

7.45M
2.90M
44.66%
4.31%
0.15%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Tel Aviv